Category: Podcast
Empowered Patient Podcast: Using Biosimulation to Develop Pediatric Therapeutics with Lynne Georgopoulos Certara
Lynne Georgopoulos, VP Regulatory Strategy, Certara describes the company’s platform to optimize pediatric drug development using biosimulation. With an eye on pediatric diseases, Certara is employing modeling and simulation to determine how a drug developed for adults may be metabolized in children, including neonates. They are also operationalizing clinical trials to be more efficient and … Continued
Episode 16 – Entrepreneurship and Consulting in Clinical Pharmacology and Pharmacometrics Part 2 with Patrick Smith and Emily Cicali
Moderated by Early Career Community member Emily Cicali, PharmD (University of Florida), Patrick Smith, PharmD (Certara) discusses the ample opportunities for small biotech companies that has arisen from changes in regulations. This episode is a great listen for anyone interested in pursuing opportunities in consulting! “More and more compounds are being developed outside the walls … Continued
Episode 15 – Entrepreneurship and Consulting in Clinical Pharmacology and Pharmacometrics Part 1 with Patrick Smith and Emily Cicali
Moderated by Early Career Community member Emily Cicali, PharmD (University of Florida), Patrick Smith, PharmD (Certara) discusses the risks and rewards with entrepreneurship in the field of clinical pharmacology and pharmacometrics. Patrick talks honestly about the mistakes made early on and the differing needs of team members who are starting a business in varying stages … Continued
Becker’s Healthcare -Pediatric Leadership Podcast – Lynne Georgopoulos, NP, VP Regulatory Strategy, Certara – Addressing Challenges in Pediatric Drug Development
Lynne Georgopoulos, NP, Vice President of Regulatory Strategy at Certara, joins the podcast to share with us her insights on pediatric drug development. She touches on the history of pediatric drug regulations, current challenges, upcoming projects and more!
Podcast – The Journal of Health Design: Dr. Craig Rayner
Dr. Rayner is President of Certara’s Integrated Drug Development and Strategic Consulting Services. In this capacity, he supports a global team of clinical and quantitative pharmacologists, pharmacometricans, regulatory strategy and drug development scientists who create value for clients across the drug development ecosystem and ultimately accelerate patients’ access to medicines. Craig has extensive global experience … Continued
The Market Access Radar (Series)
Evidence & Access – Google Podcasts (Ep. 1-3) Welcome to the Market Access Radar Podcast, your expert briefing on the latest in Market Access and Health Economics in the Bio-Pharmaceutical Industries.
COVID-19 Pharmacology Online Resource Center with Dr. Craig Rayner
Health Professional Radio – Podcast Dr. Craig Rayner, president of Certara’s Integrated Drug Development and Strategic Consulting Services discusses the COVID-19 Pharmacology Online Resource Center funded by the Bill & Melinda Gates Foundation and the programs they are working on to accelerate the treatment for COVID-19.
Good Practices in Model-Informed Drug Discovery and Development with guests Scott Marshall, Sandra Visser, and Amy Cheung
ASCPT Podcast In this episode, Drs. Scott Marshall from Pfizer, Sandra Visser from Merck, and Amy Cheung from AstraZeneca discuss “Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation”: their White Paper published in the March 2016 issue of PSP. You can get free access the White Paper by clicking here.
“Thoughtflow” with guests Mike Smith, Justin Wilkins, and Amy Cheung
ASCPT – Podcast On today’s episode, Mike Smith from Pfizer, Justin Wilkins from Occams, and Amy Cheung from AstraZeneca discuss “Thoughtflow”, a set of standards compiled by the DDMoRe consortium to help facilitate the capture, storage, and reporting of knowledge in the context of MID3, as well as to support reproducibility.
1 of 1
